Pyxis Oncology Inc expected to post a loss of 47 cents a share - Earnings Preview
20/03/2024 11:02
* Pyxis Oncology Inc PYXS.OQ PYXS.O is expected to show
a rise
in quarterly revenue when it reports results on March 22
(estimated) for the period ending December 31 2023
* The Boston Massachusetts-based company is expected to
report
revenue of $166.67 thousand, according to the mean estimate from
6 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Pyxis Oncology Inc is
for a
loss of 47 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Pyxis
Oncology
Inc is $7.50, above its last closing price of $5.15.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.49 -0.51 -0.56 Missed -10.5
Jun. 30 2023 -0.64 -0.65 -0.41 Beat 36.7
Mar. 31 2023 -0.90 -0.90 -0.55 Beat 38.8
Dec. 31 2022 -0.93 -1.01 Missed -8.7
Sep. -0.81 -0.81 -0.85 Missed -4.5
30 2022
Jun. 30 2022 -0.75 -0.76 -0.79 Missed -3.7
Mar. 31 2022 -0.61 -0.61 -0.97 Missed -59.1
Dec. 31 2021 -0.37 -1.98 Missed -442.1
This summary was machine generated March 20 at 11:02 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)